In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues | 247.8 | 194.2 | 132.2 | 63.8 |
Revenue growth | 27.6% | 47.0% | 107.1% | |
Cost of goods sold | 146.3 | 81.7 | 46.5 | 61.3 |
Gross profit | 101.5 | 112.5 | 85.7 | 2.6 |
Gross margin | 41.0% | 57.9% | 64.8% | 4.0% |
Selling, general and administrative [+] | 170.7 | 107.2 | 81.2 | 45.9 |
Sales and marketing | 10.3 | 1.9 | 1.7 | |
General and administrative [+] | 160.4 | 105.4 | 79.6 | 45.9 |
Wages and related expenses | 44.8 | 30.3 | 18.8 | |
General and administrative expenses | 115.6 | 75.1 | 60.8 | 45.9 |
Research and development | | | 0.1 | 0.6 |
Other operating expenses | -56.3 | -39.9 | -40.3 | -59.3 |
EBITDA [+] | 0.0 | 52.4 | 49.1 | 16.8 |
EBITDA growth | -100.0% | 6.8% | 192.9% | |
EBITDA margin | 0.0% | 27.0% | 37.1% | 26.3% |
Depreciation | 10.0 | 6.1 | 2.9 | 4.4 |
EBITA | -10.0 | 46.3 | 46.2 | 12.3 |
EBITA margin | -4.0% | 23.8% | 34.9% | 19.3% |
Amortization of intangibles | 12.6 | 6.7 | 5.4 | |
EBIT [+] | -22.6 | 39.6 | 40.7 | 12.3 |
EBIT growth | -157.1% | -2.8% | 230.9% | |
EBIT margin | -9.1% | 20.4% | 30.8% | 19.3% |
Non-recurring items [+] | 313.3 | 16.7 | 20.2 | 59.3 |
Asset impairment | 312.2 | 9.0 | 0.3 | 50.9 |
Restructuring charges | 1.4 | 3.1 | 1.1 | 8.4 |
Loss on contingent liability | -1.1 | 3.6 | 18.7 | |
Interest expense | 26.8 | 21.2 | 2.0 | |
Other income (expense), net [+] | 52.6 | 42.8 | -135.5 | -114.4 |
Gain (loss) on debt retirement | -4.2 | | | |
Gain (loss) on foreign currency transactions | 0.7 | 4.7 | 0.2 | |
Pre-tax income | -310.2 | 44.5 | -116.9 | -161.4 |
Income taxes | -10.8 | 28.9 | 10.8 | 1.8 |
Tax rate | 3.5% | 64.8% | | |
Minority interest | | | | -5.0 |
Earnings from continuing ops | -273.5 | 25.2 | -113.0 | -163.1 |
Earnings from discontinued ops | -25.9 | -9.5 | -14.6 | |
Net income | -299.4 | 15.7 | -127.6 | -163.1 |
Net margin | -120.8% | 8.1% | -96.6% | -255.7% |
|
Basic EPS [+] | ($1.12) | $0.14 | ($0.75) | ($1.61) |
Growth | -905.0% | -118.4% | -53.1% | |
Diluted EPS [+] | ($1.12) | $0.12 | ($0.75) | ($1.61) |
Growth | -1027.9% | -116.0% | -53.1% | |
|
Shares outstanding (basic) [+] | 244.4 | 181.1 | 149.7 | 101.3 |
Growth | 35.0% | 20.9% | 47.8% | |
Shares outstanding (diluted) [+] | 244.4 | 208.7 | 149.7 | 101.3 |
Growth | 17.1% | 39.4% | 47.8% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |